Trisense: an artificially intelligent (AI)-powered volatile organic compounds (VOC) sensing system for culture-free infection diagnosis in biofluids
Active Definitive Contract Awarded Last action
- Contract number
- HT942525CE045
- Awardee
-
Tao Treasures, LLC UEI E1Y9Z246LAU8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,299,992
Award facts
- Contract value 100% obligated
- $1,299,992.46 Current and potential, with all options
- Completion date 48% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21704, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,299,992 |
About this award
The Defense Health Agency awarded a definitive contract to Tao Treasures, LLC (doing business as Nanobiofab) for TRISENSE, an artificially intelligent volatile organic compounds sensing system for culture-free infection diagnosis in biofluids, on September 15, 2025, under a total small business set-aside. The contract carries a ceiling value of $1,299,992.46 with firm fixed price terms and an ultimate completion date of January 14, 2028.
Nanobiofab is a minority-owned, woman-owned, and Asian-Pacific American-owned small disadvantaged business based in Frederick, Maryland, where work is performed. The company specializes in advanced medical research and development leveraging artificial intelligence, nanotechnology, and intelligent sensor platforms for diagnostic and monitoring solutions serving the military health system. TRISENSE represents one of three concurrent Phase II projects awarded to Nanobiofab by the Defense Health Agency in September 2025, alongside EyeSense and a next-generation Rapid-INOSE platform, collectively valued at approximately $3.9 million. The company's federal contract portfolio with the Defense Health Agency and Department of the Army Medical Command totals approximately $8.5 million across seven prime awards, all designated as total small business set-asides.
Quick answers
Who was awarded contract HT942525CE045?
HT942525CE045 was awarded to Tao Treasures, LLC by Defense Health Agency (Department of Defense) on September 15, 2025.
How much is contract HT942525CE045 worth?
The government has obligated $1,299,992 on HT942525CE045.
Was contract HT942525CE045 competed?
The extent of competition for HT942525CE045 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award